Company Filing History:
Years Active: 2009
Title: Thierry Boon Falleur: Innovator in Cancer Research
Introduction
Thierry Boon Falleur is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of cancer research, particularly through his innovative work on peptides that have therapeutic and diagnostic implications.
Latest Patents
One of his key patents is titled "Isolated peptide which binds to HLA-Cw*07 and uses thereof." This invention focuses on peptides that consist of amino acid sequences found in MAGEA3, which bind to HLA-Cw*07 molecules to form T cell epitopes. The therapeutic and diagnostic ramifications of this invention are substantial, as are the various products developed during its creation. He holds 1 patent related to this groundbreaking work.
Career Highlights
Thierry Boon Falleur is associated with the Ludwig Institute for Cancer Research Limited, where he continues to advance his research in cancer immunotherapy. His work has been instrumental in understanding how specific peptides can be utilized in the treatment and diagnosis of cancer.
Collaborations
Throughout his career, he has collaborated with esteemed colleagues such as Pierre Van Der Bruggen and Karine Breckpot. These collaborations have further enriched his research and contributed to the advancement of cancer therapies.
Conclusion
Thierry Boon Falleur's innovative work in the field of cancer research exemplifies the impact of scientific inquiry on medical advancements. His contributions, particularly in peptide research, continue to pave the way for new therapeutic options in oncology.